Join the VISTA Clinical Trial: Advancing MS Treatment Options in Arizona
Are you living with relapsing-remitting multiple sclerosis (RRMS) in Arizona or nearby states? The VISTA Study is now enrolling participants to evaluate an innovative oral therapy, PIPE-307, that may provide new hope for individuals managing RRMS. Conducted in collaboration with Arizona Neuroscience Research, this clinical trial represents a critical step in the fight against MS.
About the VISTA Study
The VISTA Study is designed to assess the safety and potential benefits of PIPE-307, a new investigational oral therapy that targets RRMS-related disabilities. The trial is open to adults 18–50 years old with a confirmed diagnosis of relapsing-remitting MS. Whether you are on existing treatment or not, you may still qualify.
Why Participate?
- Help Advance MS Research: By joining this study, you’ll contribute to research that could pave the way for better treatments for RRMS.
- Access Innovative Care: Participants will receive comprehensive evaluations and care from specialized MS researchers and medical professionals.
- No Cost to Participate: All study-related visits, treatments, and assessments are provided at no charge.
Who is Eligible?
Participants must meet the following criteria:
- Adults aged 18–50 years
- Diagnosis of relapsing-remitting MS (RRMS)
- Eligible with or without current treatment for MS
What to Expect During the Study
The VISTA Study consists of three key parts over 34 weeks:
- Screening Phase (4 weeks):
Initial health evaluations to confirm eligibility. - Treatment Phase (26 weeks):
Participants will be randomly assigned to one of three groups:- 10 mg PIPE-307
- 20 mg PIPE-307
- Placebo (no active ingredient)
- Follow-Up Phase (4 weeks):
Post-treatment assessments to monitor safety and effects.
Why Arizona is a Hub for MS Research
Arizona’s growing clinical research infrastructure makes it an ideal location for cutting-edge studies like the VISTA Study. Residents of Arizona and neighboring states such as California, Nevada, New Mexico, and Utah have a unique opportunity to access innovative MS treatments while contributing to vital medical advancements.
How to Participate
Learn more and see if you qualify for the VISTA Study by visiting AZNeuroscienceResearch.com or contacting our team directly. Participation is voluntary, and you can withdraw at any time.
Spread the Word
If you or someone you know is living with RRMS, don’t miss this opportunity to advance MS research and explore new treatment possibilities.
#Hashtags to Share the Message
#MSResearch #ArizonaClinicalTrials #RelapsingMS #MSAwareness #PIPE307Study #NeurologyResearch #AZNeuroscience #ClinicalTrialsAZ #MultipleSclerosisTreatment
For more information on participating in clinical trials in Arizona, visit AZNeuroscienceResearch.com. Your involvement can make a difference!
